Literature DB >> 6546551

Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor.

J Y Picard, N Josso.   

Abstract

An improved method is described for the purification of anti-Müllerian hormone from incubation medium of bovine fetal testes, using RIA to optimize the yield at different steps. Proteins present in incubation medium are precipitated by ammonium sulphate at 30-45% saturation and subjected to ion-exchange chromatography on DEAE-Sepharose. The bulk of the hormone is eluted from the ion-exchanger by a 0.12 M concentration of NaCl. Purification is achieved by immunochromatography on a monoclonal antibody: usually, addition of extraneous protein to the eluting buffer is required, but can be dispensed with if a second, cumulative, immunochromatography is performed by pooling the eluates from the first procedure. AMH obtained by this procedure has been studied using Coomassie blue and immunoblotting, and compared with fucose-labelled AMH, which is recognized by the same monoclonal antibodies as the carrier of the anti-Müllerian biological activity. In the absence of reducing conditions, several multimers, from 145 000 to 235 000 in molecular weight, are present. Reduction of disulphide bond linkages results in the disappearance of the multimeric forms, and the appearance of a 72 000 monomer. Equivalence between RIA and weight units has been established in one experiment: one AMH unit corresponds to 15 micrograms of protein. Pure AMH isolated by this procedure is highly bioactive at a concentration of 200 mU/ml.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546551     DOI: 10.1016/0303-7207(84)90155-2

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  Suppressive effect of perinatal testes on the differentiation of fetal ovaries transplanted into adult males in the rat.

Authors:  Y Namba; M Yamamoto; K Atrishima; Y Eguchi
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

Review 2.  Embryology and classification of intersex states.

Authors:  N Josso
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

3.  Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

Authors:  B Knebelmann; L Boussin; D Guerrier; L Legeai; A Kahn; N Josso; J Y Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 5.  The Sertoli cell: one hundred fifty years of beauty and plasticity.

Authors:  L R França; R A Hess; J M Dufour; M C Hofmann; M D Griswold
Journal:  Andrology       Date:  2016-02-04       Impact factor: 3.842

6.  Cloning and expression of cDNA for anti-müllerian hormone.

Authors:  J Y Picard; R Benarous; D Guerrier; N Josso; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 7.  The unique endocrine milieu of the fetus.

Authors:  D A Fisher
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

8.  Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.

Authors:  A E Stephen; P T Masiakos; D L Segev; J P Vacanti; P K Donahoe; D T MacLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

9.  Illegitimate transcription: transcription of any gene in any cell type.

Authors:  J Chelly; J P Concordet; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries.

Authors:  B Vigier; M G Forest; B Eychenne; J Bézard; O Garrigou; P Robel; N Josso
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.